CClinicalTrials.gg
Active, not recruitingNCT04199871Updated Aug 25, 2026

Improving Control of Alignment in Intermittent Exotropia

An interventional study of dichoptic 3D movies in Intermittent Exotropia, sponsored by Retina Foundation of the Southwest. Active, not recruiting at 1 site in United States. Open to participants aged 3 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Retina Foundation of the Southwest · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
3 Years to 12 Years
Sex
All
01

Study summary

Aim 1: To determine whether use of dichoptic movies for 4 weeks may be helpful in improving control of alignment in children with intermittent exotropia (IXT), thus allowing IXT to be managed non-surgically Aim 2: To determine pre-IXT surgery use of dichoptic movies for 4 weeks post-operatively may be helpful in maintaining successful control of alignment in children who have surgical correction of IXT

Read the detailed description

The most common childhood-onset exotropia is intermittent exotropia (IXT). IXT is an exotropia that is not constant and is mainly present at distance, but may also be present at near. Binocular single vision is typically present at near but may be subnormal. There is some debate in the literature about whether or not these children should be treated surgically to correct the misalignment. It can be argued that prompt surgical correction is necessary to prevent the development of suppression of the deviating eye, progression to constant exotropia, and permanent changes in sensory function that may compromise long-term post-operative outcomes. On the other hand, statistics on the natural history of IXT suggest that progression to constant XT occurs in less than 25% and up to 15% may improve spontaneously. These findings suggest a more conservative approach, using surgery only if deterioration of the IXT occurs. A recent randomized clinical trial of the two most common surgical techniques for IXT revealed a 3-year postoperative failure rate of approximately 40% (PEDIG 2019; Ophthalmology 126: 305-17). For the vast majority of children, surgical failure was due to recurrence of the exodeviation. Only about 30% of treated children had resolution of IXT at the 3-year visit. Similarly, a literature review of 28 surgical studies that included 2530 children with IXT reported a suboptimal surgical outcome at 1-year post-op in approximately 40% of children. (Coffey et al 1992; Optom Vis Sci 69: 386-404).

Poor surgical results for IXT are thought to occur due to poor sensory status (suppression) or inadequate motor alignment. There are few data on the effects of non-surgical interventions designed to improve sensory status of children undergoing surgery for IXT. Although several retrospective case reviews found evidence supporting a benefit of pre-op sensory and motor fusion training on IXT surgical outcomes, there have been no prospective studies or randomized clinical trials. One of the largest retrospective case series (Cooper \& Leyman 1977; Am Orthoptic J 27:61-7) compared 216 patients with IXT who had sensory and motor fusion training prior to surgery with 264 who had surgery alone and found a higher rate of good surgical outcomes (52% vs 42%). There are no published data on post-op interventions to improved sensory status.

In this study, engaging movies will be presented on a handheld Nintendo to decrease suppression and engage stereoacuity. In previous research, use of dichoptic games and movies by children with amblyopia has been shown to reduce suppression and encourage sensory fusion (Birch et al 2015, JAAPOS 19:6-11; Birch et al 2019, JAAPOS [Epub ahead of print]; Kelly, Jost, et al 2016; JAMA Ophthalmol 134:1402-8.; Kelly et al Invest 2018 Ophthalmol Vis Sci 59:1221-8; Li et al 2014; Eye 28: 1246-53). This approach will be adapted by using dichoptic movies presented on a Nintendo for children with IXT to improve their stereoacuity and reduce their suppression in an effort improve control of alignment sufficiently without surgery (Aim 1) or to improve stability of post-operative alignment (Aim 2).

02

Conditions studied

  • Intermittent Exotropia
03

Who can participate

Ages eligible
3 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of IXT
  • IXT control assessment score at distance of 3 or 4 at baseline
  • Ocular misalignment by PACT >10 pd at distance and near or PACT >15 at distance or near

Exclusion criteria

Exclusion Criteria:

  • Amblyopia
  • Prior surgery
  • Prior binocular treatment
  • Coexisting ocular or systemic condition
  • Developmental delay
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Group1

    dichoptic 3D movies

    Other: dichoptic 3D movies

  • Sham comparator
    Group 2

    dichoptic standard movies

    Other: dichoptic 3D movies

Interventions

  • Otherdichoptic 3D movies

    dichoptic movies presented on a Nintendo 3DS

    Also known as: dichoptic standard movies

05

What researchers measure

Primary outcomes

  1. Alignment Control Score

    Classification system developed by PEDIG to quantify the degree of control of ocular alignment on a 0-5 scale at distance and near; 0 is best control \[no exotropia unless dissociated, recovers in \<1 second (phoria)\] and 5 is worst control (constant exotropia)

    Time frame: 3 months

Secondary outcomes

  1. Stereoacuity at distance

    Randot Distance Stereoacuity Test

    Time frame: 3 months

  2. Binocular fixation stability

    Stability of the vergence angle assessed by recording eye movements during 20 sec fixation

    Time frame: 3 months

  3. Stereoacuity at near

    Randot Preschool Stereoacuity Test

    Time frame: 3 months

06

Study locations

1 site
  • Eileen E Birch
    Dallas, Texas 75231, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04199871
Lead sponsor
Retina Foundation of the Southwest
Responsible party
Eileen Birch (Senior Research Scientist, Retina Foundation of the Southwest) — Principal investigator
First posted
Dec 16, 2019
Start date
Mar 25, 2021
Primary completion
Jun 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Aug 25, 2026

Study contacts

Eileen E Birch, PhD
principal investigator · Retina Foundation of the Southwest

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion